| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10220228 | Gynecologic Oncology | 2018 | 9 Pages |
Abstract
In this cohort of women with stage IA endometrial cancer of unfavorable histology, the use of BT was associated with improved survival. In this study, 29.5% of patients in our cohort received BT.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ashwin Shinde, Richard Li, Arya Amini, Yi-Jen Chen, Mihaela Cristea, Thanh Dellinger, Wenge Wang, Mark Wakabayashi, Sushil Beriwal, Scott Glaser,